I-Strides Pharma Science Limited (Strides) namuhla imemezele ukuthi inkampani engaphansi kwayo ephethwe ngokuphelele, i-Strides Pharma Global Pte. I-Limited, Singapore, ithole ukugunyazwa kwe-Tetracycline Hydrochloride Capsules USP, 250 mg kanye no-500 mg kwa-United States Food & Drug Administration (USFDA). Umkhiqizo inguqulo evamile ye-Achromycin V Capsules, 250 mg kanye 500 mg, ye-Avet Pharmaceuticals Inc (ngaphambilini eyayiyi-Heritage Pharmaceuticals Inc.)Ngokwedatha ye-IQVIA MAT, imakethe yase-US ye-Tetracycline Hydrochloride Capsules USP, 250 mg icishe ibe ngu-50 mg US$16 Mn. Umkhiqizo uzokhiqizwa endaweni ephambili yenkampani e-Bangalore futhi uzomakethwa yi-Strides Pharma Inc. emakethe yase-US. Le nkampani ine-ANDA cumulative 123 ne-USFDAs angu-84 ANDAs agunyaziwe kanti angu-39 asalinde ukuvunywa.I-Tetracycline Hydrochloride I-Capsule iyi-antibiotic esetshenziselwa ukwelapha izifo eziningi ezihlukahlukene ze-bacterial esikhumbeni, amathumbu, umgudu wokuphefumula, umchamo. amapheshana, izitho zangasese, ama-lymph nodes, nezinye izinhlelo zomzimba. Kwezinye izimo, i-tetracycline Hydrochloride Capsule isetshenziswa lapho i-penicillin noma esinye isibulala-magciwane singakwazi ukusetshenziselwa ukwelapha izifo ezibucayi njenge-Anthrax, Listeria, Clostridium, Actinomyces.Amasheya e-Strides Pharma Science Ltd agcine ukuhweba nge-BSE ngama-Rs.466.65 uma kuqhathaniswa ne- ukuvalwa kwangaphambilini kwama-Rs. 437. Isamba senani lamasheya adayiswe phakathi nosuku lalingu-146733 emisebenzini engaphezu kuka-5002. 473.4 kanye ne-intraday low 440. Inzuzo yonke emini yayingama-Rs. 66754491.